P latelet glycoprotein VI (GPVI) is a member of the immunoglobulin-like protein family that is an essential platelet receptor for collagens 1 and is exclusively expressed in the megakaryocytic lineage. 2, 3 We recently reported a variation in platelet GPVI content among normal healthy individuals that correlated well with convulxin-induced platelet prothrombinase activity. 4 Although platelet GPVI levels are most likely under genetic control, the responsible mechanism has yet to be determined. A requisite first step in understanding the regulation of expression of this gene is a characterization of its 5Ј regulatory region and promoter properties. Considering the critical role of GPVI in collageninitiated signal transduction and platelet procoagulant activity, the observed variation in GPVI content may influence risk for hemorrhagic or thromboembolic disorders. From a clinical standpoint, it would be important to ascertain the mechanism(s) that controls GPVI content and to screen individuals for predisposition to thromboembolic disorders.
The promoter regions of megakaryocytic-specific genes, such as the integrin subunit ␣ IIb , 5, 6 platelet factor-4, 7 platelet glycoprotein V, 8 and platelet glycoprotein Ib␣, 9 share a number of common characteristics. In each case, the core promoter is generally short (Յ500 bp), it lacks CCAAT or TATA consensus sequences, and it has functional GATA, Sp-1, and Ets cis-acting elements. 10, 11 GATA and Ets factors are not exclusive to the megakaryocyte lineage but are also critical for expression of erythroid-restricted and other unrelated genes, such as platelet and endothelial cell adhesion molecule-1 12 and P-selectin. 13 Among megakaryocyte-specific genes, the ␣ IIb promoter has been the best studied. The human ␣ IIb promoter has a positive regulatory element in its 5Ј region (from Ϫ598 to Ϫ400), wherein there are an Ets binding motif at Ϫ515 and a GATA-1 binding motif at Ϫ463. Both of these elements seem to play important roles in the expression of ␣ IIb . 6 Three groups have postulated that there is a silencing element in the ␣ IIb promoter that suppresses expression of the ␣ IIb promoter in all cells except those of the megakaryocyte lineage. 5, 14, 15 However, Era et al, 6 using in vitro differentiation of murine D3 embryonic stem cells, recently refuted this observation and observed that solely a positive regulatory element in the region from Ϫ598 to Ϫ400 is sufficient for megakaryocyte lineage-specific expression of the ␣ IIb gene. 6 Likewise, Albanese et al 16 reported that the GATA element at Ϫ463 and a flanking region of the human ␣ IIb promoter were sufficient for restoring megakaryocyte lineage-specific expression of the murine ␣ IIb gene in human cell lines. On the basis of these observations, it seems likely that positive regulatory elements play a prominent role in defining the lineage specificity of the human ␣ IIb promoter.
To elucidate the mechanism of megakaryocyte lineagespecific expression of GPVI, we first excised a 1.5-kb fragment of the GPVI gene (GP6) 5Јregulatory region from a BAC clone harboring the human gene (Clone 211(12) Incyte Genomics) and inserted this segment into pGL3-basic, upstream from a luciferase reporter gene. By luciferase assays and DNase I footprinting, we determined that a region of GP6 spanning from Ϫ191 to Ϫ39, which contains 1 GATA-1 and 1 Ets-1 binding site, is necessary for the transcriptional activity of GP6 in transfected cell lines. From a comparison of genomic DNA of 17 normal volunteers, 3 dimorphisms in the GP6 5Ј regulatory region were found to be in linkage disequilibrium, defining 2 major haplotypes.
Methods

Cell Lines and Blood Samples
The human cell line HeLa was purchased from the American Type Culture Collection (Manassas, Va). A Dami cell clone was received as a gift from Dr David Wilcox (Medical College of Wisconsin, Milwaukee). These cell lines were grown in DMEM supplemented with 10% FBS (HeLa) or Iscove's modified Dulbecco's medium supplemented with 10% horse serum (Dami). Blood samples were obtained by medical personnel of The Scripps Clinic General Clinical Research Center from normal human volunteers, as described previously, 4 with informed consent.
RACE
Online Table I (please see http://www.ahajournals.org) summarizes the GP6-specific oligonucleotide primers that are referred to in the present study. Total RNA was extracted from washed platelets with the use of an RNAqueous RNA extraction kit (Ambion) according to the manufacturer's instructions. First-strand cDNA was synthesized by using a RETROscript reverse transcription-polymerase chain reaction (PCR) first-strand synthesis kit (Ambion) and primer GSP1 (5Ј-CCATGATCCCTCCCTTGGAT-3Ј). The remaining RNA was digested with a combination of RNase H and RNase T1 (GIBCO-BRL), and then the GP6-specific first-strand cDNA was purified with the use of a GENECLEAN III kit (BIO 101) and tailed with dCTP by use of terminal deoxynucleotidyl transferase (Roche Molecular Biochemicals). The tailed cDNA was amplified by PCR with the use of 5Ј RACE anchor primer (GIBCO-BRL, 5Ј-GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG-3Ј) and primer GSP2 (5Ј-CCTGCTGGAGAAGCTGTAGCA-3Ј), followed by a second round of PCR with the use of Abridged Universal Amplification Primer (GIBCO-BRL, 5Ј-GGCCACGCGT CGACTAGTAC-3Ј) and primer GSP3 (5Ј-GAGGCTTCC-GTTCTGGTAGGAGCA-3Ј). The PCR product was gel-purified, subcloned into pGEM-T Easy vector (Promega), and sequenced.
Comparison of Human and Murine GP6 Sequence
The human and murine GP6 sequences were retrieved from the GenBank high-throughput gene sequence (htgs) database (human clone RP11-700B5 and mouse clone RP23-106A10, respectively) by using the appropriate cDNA as query sequence and the BLAST algorithm (available at http://www.ncbi.nlm.nih.gov/BLAST/blast_references.html). The sequences of these BAC clones are not yet fully refined, and contigs within the obtained sequences are unordered. On the basis of the corresponding cDNA sequence, we established the correct order of the genomic contigs before the corresponding sequences from each species were compared with one another with use of the Vista software package (available at http://www-gsd.lbl.gov/VISTA).
Generation of Human GP6 Promoter Constructs
Online Table II (please see http://www.ahajournals.org) summarizes the GP6 promoter constructs created for the present study. A BAC clone harboring human GP6 was identified at Incyte Genomics, Inc, by PCR-based screening of a human genomic library with the use of primer 6.1 (5Ј-GAGAAGCCAGTGACCCTCCGGTG-3Ј) and primer GSP3, generated in our laboratory. The proximal 5Ј region of GP6 (Ϫ1576 to 75) was then amplified from this BAC clone DNA by PCR with the use of primers GP6P1F (5Ј-CGGGTACCTGGAGACAGAATCTCGCTCTG) and GP6PR (5Ј-CTCGAGCCTCAGGACTCACCAAGACAG-3Ј). The amplified PCR product was subcloned into pGEM-T easy vector (Promega) and sequenced. A 1651-bp KpnI-XhoI fragment with the correct sequence was then excised from this vector and subcloned into the luciferase reporter plasmid pGL3-basic (Promega), creating pGL3(Ϫ1576). A shorter 1577-bp XmaI-XhoI DNA fragment spanning Ϫ1502 to 75 was obtained from pGL3(Ϫ1576) and cloned into pGL3-basic, creating pGL3(Ϫ1502). This construct was subsequently used as a template for generation of a series of 5Ј-end unidirectional truncation mutants. In brief, pGL3(Ϫ1502) was first digested with a combination of KpnI and XmaI, and then its 5Ј end was unidirectionally truncated by using the Erase-A-Base Kit (Promega), creating pGL3(Ϫ1325), pGL3(Ϫ937), and pGL3(Ϫ539). An internal deletion mutant was constructed by PCR-based 2-step mutagenesis from pGL3(Ϫ1502) such that this mutant, pGL3-del(Ϫ191), bears a deletion of the segment between Ϫ191 and Ϫ39.
To more precisely locate the core promoter of GP6, 4 overlapping DNA fragments were amplified by PCR from the genomic DNA of each of 1 high-content and 1 low-content donor 4 by using 1 of the 4 forward primers: Ϫ322 (5Ј-CCCGGGAGCCATTCCAGAAG-GTGTGA-3Ј), Ϫ191 (5Ј-CCCGGGAGGCTGGCCAGAGGA-GATAA-3Ј), Ϫ159 (5Ј-CCCGGGGGAGCTTGTGTGCAAGT-CAC-3Ј), and Ϫ38 (5Ј-CCCGGGGCCTGTGCCCCAGGCTCCCA-3Ј) together with the common reverse primer, GP6PR. After nucleotide sequencing of the DNA fragments subcloned in pGEM-T easy, the 4 GP6 promoter constructs were each subcloned into pGL3-basic, and the resultant constructs were designated pGL3(Ϫ322), pGL3(Ϫ191), pGL3(Ϫ159), and pGL3(Ϫ38). The substitution mutant pGL3(⌬GATA) was made by PCR-based mutagenesis from pGL3(Ϫ322), whereby the consensus GATA motif at Ϫ176 was mutated to GAGC. Similarly, in the mutant pGL3(⌬Ets), the Ets-1 site at Ϫ45 was mutated from ACATCCTG to ACACTTCG, whereas in the combined mutant pGL3(⌬GATA/Ets), the GATA-1 and Ets-1 sites were mutated. The sequences of all mutants were confirmed before use.
The murine counterparts of the core promoter regions Ϫ193 to 75 and Ϫ159 to 75 were amplified from mouse genomic DNA by PCR with the use of corresponding primers designed from the sequence of Mus musculus clone RP23-106A10 (GenBank accession No. AC087129). After verifying sequences, these were also subcloned into pGL3-basic to generate pGL3(m-193) and pGL3(m-159).
Transient Expression Analysis of GP6 Promoter Activities by Luciferase Assay
Dami cells were transfected with 1 of the pGL3-GP6 promoter constructs together with the Renilla luciferase reporter vector pRL-TK (Promega) by using the Effectene transfection reagent (Qiagen). In brief, 5ϫ10 5 Dami cells were transfected with a combination of 0.1 g of pRL-TK and 0.2 g of 1 of the pGL3-GP6 promoter constructs. Additional cells were transfected with the pGL3-control vector (Promega) and pRL-TK in the same medium. The cells were cultured for 48 hours in the presence of the DNA mixture and then harvested. Firefly and Renilla luciferase activities were measured on a luminometer by using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. To normalize for transfection efficiency, the promoter activity of each construct was expressed as the ratio of firefly luciferase activity to Renilla luciferase activity. When experiments in different cell lines were compared, the results were expressed as the ratio of GP6 activity to pGL3-control activity.
DNase I Footprinting
To confirm the occupancy of putative transcription factor binding elements in the GP6 core promoter region, we performed DNase I-based footprinting with the use of nuclear extracts from Dami and HeLa cells. The nuclear extract of HeLa cell (HeLaScribe Nuclear Extract) was purchased from Promega, and that of Dami was prepared by the method of Dignam et al. 17 The footprinting reaction was performed by using the Core Footprinting System (Promega) according to the manufacturer's instructions with minor modifications. Briefly, 5 g pGL3(Ϫ322) was digested with XhoI and then dephosphorylated at its 5Ј ends with calf intestine alkaline phosphatase. After 32 P-labeling of both 5Ј ends with the use of T4 polynucleotide kinase, the DNA fragment was further digested with XmaI, and the resultant 397-bp DNA fragment (probe) was gel-purified. This probe was incubated either with 20 g or 50 g Dami nuclear extract or 40 g HeLa nuclear extract for 30 minutes at ambient temperature; a control was incubated in the absence of nuclear extract. The DNA-protein mixture was subjected to RQ1 RNase-free DNase digestion for 2 minutes at ambient temperature. Each reaction mixture was extracted with phenol-chloroform and subjected to electrophoresis on a 6% denaturing sequencing acrylamide gel together with sequence ladders of the same probe. The latter were obtained by using a femtomole DNA Cycle Sequencing System (Promega) and served to locate the occupied sites. The gel was dried and exposed to x-ray film with an intensifying screen at Ϫ70°C.
EMSA for GATA-1 at ؊176 and Ets-1 at ؊45 Double-stranded DNA probes were obtained by annealing the following individually synthesized single-stranded oligonucleotides: for GATA Ϫ176 (nucleotides Ϫ185 to Ϫ166, 5Ј-GCCAGAGGAGATAAGCGCGG-3Ј); for Ets Ϫ45 (nucleotides Ϫ51 to Ϫ32, 5Ј-CATCACATCCTGAGCCTGTG-3Ј). The probes were 5Ј end-labeled with 32 P before electrophoretic mobility shift assay (EMSA). The following double-stranded competitors were similarly synthesized: GATA mutant (5Ј-GCCAGAGGAG-AGCAGCGCGG-3Ј), GATA consensus (5Ј-CACTTGATA-ACAGAAAGTGATAACTCT-3Ј; GATA Gel Shift Oligonucleotides, Santa Cruz Biotechnology), Ets mutant (5Ј-CATCACACTTCGAGCCTGTG-3Ј), Ets consensus (5Ј-GATCTCGAGCAGGAAGTTCGA-3Ј; Ets-1/PEA3 Gel Shift Oligonucleotides, Santa Cruz Biotechnology), and PU.1 consensus (5Ј-GGGCTGCTTGAGGAAGTATAAGAAT-3Ј; Ets Family Gel Shift Oligonucleotides, Santa Cruz Biotechnology). The same HeLa and Dami nuclear extracts prepared for DNase I footprinting were used in this assay.
Each 32 P-labeled probe (50 fmol) was mixed with 10 g nuclear extract, 2 g poly(dI-dC) (Amersham Pharmacia Biotech), and 10-fold or 100-fold molar excess of competitor in the binding buffer (25 mmol/L HEPES, pH 7.9, containing 10% [vol/vol] glycerol, 50 mmol/L KCl, 0.5 mmol/L EDTA, 0.5 mmol/L phenylmethylsulfonyl fluoride, and 0.5 mmol/L dithiothreitol) and incubated at ambient temperature for 30 minutes. Samples were then analyzed in a 4% or 5% polyacrylamide gel with the use of a running buffer of 50 mmol/L Tris and 0.38 mol/L glycine, pH 8.5, containing 5 mmol/L EDTA. After electrophoresis, the gel was dried and exposed to x-ray film.
Nucleotide Sequence Variation in the 5 Regulatory Region of GP6
Genomic DNA was isolated from peripheral blood leukocytes of each of 1 high-content and 1 low-content GPVI donor 4 by using the Puregene DNA isolation kit (Blood kit, Gentra Systems). A DNA fragment of 1.5 kb corresponding to the GP6 5Ј regulatory region was amplified by PCR by using primers KpnI-GP6P1F (5Ј-CGGGTACCTGGAGACAGAATCTCGCTCTG-3Ј) and BglII-GP6P1R (5Ј-CGAGATCTCACAGGCTCAGGATGTGATG-3Ј) and then directly sequenced.
We identified a T/C dimorphism at Ϫ126 and 2 nearby dimorphisms of G/A at Ϫ1536 and T/C at Ϫ1530 between the high-and low-content GP6 donor sequences. To obtain genotypic frequencies of these dimorphisms, we similarly extracted genomic DNA from 15 more subjects. A genomic DNA fragment encompassing the 2 nearby dimorphisms was amplified by seminested PCR with the use of primers GP6P1F and GP6P1R in a primary PCR reaction and then GP6P1F and GP6P4R (5Ј-AGCCTGGGCAACACAGTAAA-3Ј) in a secondary, seminested PCR reaction. The 196-bp DNA product was directly sequenced to identify the Ϫ1536 G/A and Ϫ1530 T/C dimorphisms. Another T/C dimorphism at Ϫ126 was genotyped by NaeI digestion of a 444-bp PCR product obtained with primers GP6P2F (5Ј-TGGGCAAAAAGAACGAGACT-3Ј) and GP6PR. NaeI cuts the DNA fragment bearing Ϫ126C (GCCGGC), yielding 200-bp and 244-bp fragments in individuals homozygous for Ϫ126C. In individuals homozygous for Ϫ126T, a single 444-bp fragment is obtained. In individuals heterozygous for this dimorphism, 3 fragments are obtained: at 444, 244, and 200 bp. 
DNA Sequencing
Results
RACE
A 330-bp DNA fragment was obtained after the final round of PCR. Three of the 5 sequenced clones began at an adenine located 28 bases upstream from the translation start codon ATG ( Figure 1) ; the remaining 2 clones began at a cytosine located adjacent to and 1 base downstream from the aforementioned adenine. Consequently, we assigned the major transcription start site for GP6 to the adenine located 28 bases upstream from the ATG. This experimental finding confirms the transcription start site predicted in the report of Ezumi. 18 This transcription start site is only 3 bases upstream from the original GP6 cDNA sequence obtained by primer extension. 2 Throughout the present article, all of the nucleotides in the Figure 1 . Nucleotide sequence of the 5Ј region of GP6. The major transcription start site for GP6 was revealed by 5Ј RACE to be an adenine located 28 bp upstream from the ATG translation start site. Notable transcription factor binding motifs in the region from Ϫ191 to 75 were identified by using MatInspector 25 and are indicated.
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GP6 5Ј regulatory region are numbered relative to the adenine base transcription start site, now designated 1.
Vista Analysis of Homologous Regions Between Human and Murine GP6
Both the GP6 sequences of the Mus musculus clone RP23-106A10 (GenBank accession No. AC087129) and Homo sapiens chromosome 19 clone RP11-700B5 (GenBank accession No. AC019238) were reordered regarding the corresponding cDNA sequences. By comparing the murine and human GP6 sequences with use of the Vista software package, we were able to identify highly homologous sequences in the region immediately 5Ј to exon 1. Within the proximal portion of the GP6 5Ј regulatory region, there is 1 conserved noncoding sequence (CNS) in which the human and murine sequences exhibit 77% identity over a 257-bp segment that spans from Ϫ182 to 75 (human sequence numbering; online Figure I , available at http://www.ahajournals.org). The high degree of homology within this sequence between these evolutionarily disparate species implies an important function for this region of the GP6 gene.
Characterization of the 5 Regulatory Region of GP6 by Luciferase Reporter Assay
The plasmid pGL3(Ϫ1576) contains a segment of the GP6 5Ј regulatory region DNA from nucleotide Ϫ1576 to 75 that includes the 5Ј regulatory region and exon I, which encodes the first 11 amino acids of the signal peptide, as well as a part of intron I. A second plasmid, pGL3(Ϫ1502), contains the same GP6 DNA but spans from Ϫ1502 to 75. A series of 5Ј unidirectional deletion mutants (online Table II) were derived from pGL3(Ϫ1502), as described in Methods, and tested for their ability to drive the luciferase reporter gene in transiently transfected Dami cells. Figure 2 summarizes the results of these transfection studies.
Relative to pGL3(Ϫ1576), pGL3(Ϫ1325) showed a 50% decrease in promoter activity, whereas pGL3(Ϫ937) exhibited a 24% increase in activity. These findings suggest that negative regulatory elements are located in a region between Ϫ1325 and Ϫ937. Relative to pGL3(Ϫ937), pGL3(Ϫ191) exhibited an Ϸ50% decrease in activity, and pGL3(Ϫ159) showed a Ͼ75% decrease in activity. These results indicate that the GP6 core promoter elements are located downstream from Ϫ191 and that there is an essential positive control element within the sequence spanning from Ϫ191 to Ϫ159. Qualitatively similar findings were obtained in K562 cells transfected with the same reporter constructs (not shown).
To evaluate cell-type specificity of the GP6 promoter, the same promoter constructs were transfected into HeLa cells, and luciferase activities were similarly measured. Although pGL3(Ϫ937), pGL3(Ϫ539), and pGL3(Ϫ322) showed very weak promoter activities in HeLa cells, pGL3(Ϫ191) and pGL3(Ϫ159) showed little if any activity (Figure 2 ). Mutation of GATA at Ϫ176 decreased the promoter activity of pGL3(⌬GATA) in Dami cells compared with its parent construct, pGL3(Ϫ322), but showed no effect on the promoter activity in Hela cells.
Contribution of GATA and Ets Elements to GP6 Core Promoter Activity
The deletion of the sequence Ϫ191 to Ϫ39 from pGL3(Ϫ1502) resulted in a 62% decrease in the activity of pGL3-del(Ϫ191) in transfected Dami cells, confirming that a major positive regulatory element resides within this segment (Figure 3) . Within the Ϫ191/Ϫ39 region, there are 1 GATA-1 binding site at Ϫ176 and 1 Ets-1 binding site at Ϫ45 (Figure  1) . To measure the contribution of these GATA-1 and Ets sites to promoter activity, we generated and tested 3 shorter promoter constructs, pGL3(Ϫ191), pGL3(Ϫ159), and pGL3(Ϫ38), in Dami cells. Although pGL3(Ϫ191) retained Ϸ80% of the activity of pGL3(Ϫ1502), deletion of a segment from Ϫ191 to Ϫ160, which contains the GATA-1 site at Ϫ176, decreased the promoter activity of pGL3(Ϫ191) by 4-fold. A further removal of the sequence from Ϫ159 to Ϫ39 decreased the promoter activity of pGL3(Ϫ38) to background Determination of GP6 core promoter sequence. An internal deletion mutant, pGL3-del(Ϫ191 to Ϫ39), and 5Ј truncation mutants were generated from a parent GP6-luciferase construct, pGL3(Ϫ1502), as described in Methods. Dami cells were transiently transfected with each of the promoter-luciferase reporter gene constructs together with pRL-TK, and firefly and Renilla luciferase activities were determined. Mean (solid bars) and 1 SD are shown.
level. The Ϫ159/Ϫ39 segment contains predicted binding sites for c-Rel, PU.1, and c-Ets-1.
The murine GP6 sequence corresponding to the human sequence Ϫ191 to Ϫ160 is also a positive regulatory element (online Figure II , available at http://www.ahajournals.org). This segment also contains a T/C dimorphism at Ϫ126 that is in linkage disequilibrium with 2 dimorphisms, Ϫ1536 G/A and Ϫ1530 T/C. The Ϫ126T and the Ϫ126C haplotypes were transfected into Dami cells in the context of pGL3(Ϫ322) and pGL3(Ϫ159). In either case, no significant differences were observed between promoter activities of the 2 haplotypes (data not shown).
Site-directed mutagenesis confirmed the positive regulatory role of the GATA-1 site at Ϫ176 and the Ets-1 site at Ϫ45. As illustrated in Figure 4 , substitution mutation of the GATA-1 site decreased the promoter activity by 30%, whereas that of the c-Ets-1 site decreased the promoter activity by 40%. The combined mutation of the GATA-1 and c-Ets-1 sites decreased the promoter activity by 3-fold, suggesting an additive effect of these transcription factors.
Transcription Factor Binding Sites Within the 191 Nucleotides Preceding the Transcription Start Site
A number of transcription factor binding motifs are present in the putative core promoter sequence of GP6 (Figure 1 ). To investigate whether any of these motifs can be bound by nuclear proteins from megakaryocytic lineage cells, we performed DNase I footprinting ( Figure 5 ). The GATA-1 site at Ϫ176 was clearly occupied by a Dami nuclear protein(s) but not by HeLa nuclear proteins, suggesting in vivo involvement of the GATA-1 site for megakaryocyte lineage-specific expression of GPVI. However, other predicted transcription factor binding motifs, including c-Rel and PU.1, were apparently not occupied by Dami nuclear proteins in the DNase I footprinting. The c-Ets-1 motif at Ϫ45 might be protected, inasmuch as 2 bands indicated by arrowheads in Figure 5B were present in lane 4 but absent in lanes 2 and 3. However, absence of the bands in lane 1(control) makes it difficult to conclude that the c-Ets-1 site is actually protected by Dami nuclear protein.
Binding of Nuclear Proteins to Transcription Factor Binding Motifs
Using electrophoretic mobility shift analysis, we found that nuclear proteins from Dami but not from HeLa cells bind to a 20-bp core promoter fragment (nucleotides Ϫ185 to Ϫ166) that contains the GATA-1 binding motif ( Figure 6A ). Unlabeled probe (self DNA) and consensus GATA DNA competed away this binding in a dose-dependent manner. However, the mutated self-competitor, in which GATA sequence was mutated to GAGC, did not affect the binding of Dami nuclear protein to the probe. In agreement with the DNase I footprinting results, these observations clearly indicate that the Dami nuclear protein selectively binds to the GATA-1 motif on the probe.
Similarly, Dami nuclear proteins bound to the c-Ets-1 probe ( Figure 6B ). However, this binding was blocked only by self-competitor and the consensus PU.1 DNA but not by a consensus Ets competitor DNA. The thick band observed in Figure 6A and 6B was considered to be a nonspecific band because it was observed with Dami and Hela nuclear extract and because it was not affected by any competitor.
Discussion
GPVI is a platelet-specific collagen receptor that belongs to the killer cell receptor subgroup of the immunoglobulin gene family 2, 3 and cooperates with integrin ␣ 2 ␤ 1 in vivo to effect optimal collagen-induced platelet adhesion and activation.
In many respects, the GP6 5Ј regulatory and promoter regions resemble those of other genes encoding megakaryocyte lineage-specific proteins. [5] [6] [7] [8] [9] Most notably, the GP6 promoter does not have a TATA box 18 but contains functional GATA-1 and Ets-1 binding motifs. In luciferase reporter assays using 5Ј unidirectional deletion mutants of the GP6 5Ј regulatory region, we determined that the core promoter of GP6 lies within the sequence from Ϫ191 to Ϫ39. This region 
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Human GP6 5 Regulatory and Promoter Regionsis highly conserved between human and mouse GP6, as revealed by Vista analysis, and there is roughly 77% identity within a 259-bp segment from position Ϫ182 to 75 (human sequence numbering). One GATA-1 site at Ϫ176 and 1 c-Ets-1 site at Ϫ45 were identified in the core promoter. Deletion of the sequence Ϫ191 to Ϫ160 significantly decreased activity in transfected Dami cells, indicating that an essential positive regulatory element exists within this sequence. Several lines of evidence confirmed that GATA-1 at Ϫ176 is the essential element. First, mutation of the GATA-1 site decreased the promoter activity in Dami cells by 30%. Second, this GATA-1 motif is fully conserved between the human and murine GP6 sequences. Third, binding of Dami cell nuclear protein to this sequence was confirmed by DNase I footprinting and EMSA, where this binding was effectively blocked by consensus GATA oligonucleotides.
The GP6 promoter is also regulated by Ն1 Ets binding protein, and mutation of the Ets binding element at Ϫ45 resulted in a 40% decrease in activity in transfected Dami cells. Concomitant mutation of the GATA-1 and Ets-1 binding elements decreased the promoter activity by 3-fold, indicating an additive effect of GATA-1 and Ets-1. This conclusion is confirmed by the finding that deletion of Ϫ159 to Ϫ39 decreases promoter activity to almost the background level in Dami cells. However, it was not clear whether the Ets-1 site at Ϫ45 was protected in DNase I footprinting assays. The binding of an Ets family transcription factor to this site may be too weak to be detected by DNase I footprinting, or DNase I may not cut the segment of the probe corresponding to the Ets-1 site to yield a band to be protected.
Ets family transcription factors have been implicated in megakaryocyte lineage-specific expression of a number of genes. 5-9,19 -21 For example, Ets-1 is involved in the regulation of platelet factor 4, 7 PU.1 is implicated in the expression of platelet basic protein, 19 and Fli-1 contributes to the regulation of glycoprotein IX expression. 20 The contribution of Ets family proteins to the regulation of ␣ IIb expression is less clear. Era et al 6 demonstrated that c-Ets-1 is not involved by showing that c-ets-1-null murine embryonic stem cells differentiate normally into megakaryocytes in vitro and that the level of LacZ expression driven by the ␣ IIb core promoter in c-ets-1-null murine megakaryocytes is similar to that observed in wild-type megakaryocytes.
In Fli-1 knockout mice, among the megakaryocyte lineage-specific transcripts that might be regulated by Ets proteins, including platelet glycoprotein IX, platelet glycoprotein IIb, c-mpl, and vwf, only platelet glycoprotein IX transcription is decreased. 22 It is unlikely that the expression of GP6 is regulated by Fli-1 because the GP6 promoter constructs that we tested showed nearly identical activities in Dami and K562 cells, and K562 is known to not express Fli-1. 20 Another member of the Ets family, PU.1, is essential in the development of cells of the monocytic, granulocytic, and lymphoid lineage and is known to be a potential cross-antagonist of GATA-1. 23 Because in the case of GP6, the Ets-1 family protein in question cooperates additively with GATA-1, it is unlikely that PU.1 is the Ets family protein that controls the GP6 promoter. Further studies are required to identify and characterize the Ets family protein that is responsible for the control of GP6 promoter.
In normal subjects, we identified 3 GP6 sequence dimorphisms at Ϫ1536, Ϫ1530, and Ϫ126, which are in linkage disequilibrium and define 2 haplotypes: G-T-T and A-C-C. The T/C dimorphism at Ϫ126 lies within the GP6 core promoter region but has no effect on promoter activity in transfected Dami cells. The other 2 dimorphisms are located in a region of the 5Ј gene sequence that does not contribute significantly to promoter activity, inasmuch as deletion of these sequences has no effect. To further evaluate a possible contribution of these haplotypes to the control of platelet GPVI levels, we compared haplotype frequencies in a group of 17 randomly selected donors. There is no statistically significant correlation between these haplotypes and platelet GPVI content (data not shown). Because platelet GPVI levels are correlated with integrin ␣ 2 ␤ 1 densities 4 and because the appearance of GPVI during human megakaryocyte maturation coincides temporally with the appearance of integrin ␣ 2 ␤ 1 , 24 it is possible that there is a common mechanism involved in the coordinated expression of these important collagen receptors.
The characterization of the GP6 5Ј regulatory region, as described in the present study, represents an important preliminary step in the elucidation of the precise molecular mechanisms responsible for the control of platelet GPVI levels. Figure 6 . Binding of nuclear proteins to transcription factor binding motifs. Nuclear extracts (NEs) were prepared from Dami and Hela cells and incubated with radiolabeled oligonucleotides either corresponding to GATA-1 at Ϫ176 (nucleotides Ϫ185 to Ϫ165, A) or Ets-1 at Ϫ45 (nucleotides Ϫ51 to Ϫ32, B) in the presence of 10-fold or 100-fold molar excess of cold competitor oligonucleotides as indicated. A thick nonspecific band was observed with both oligonucleotides incubated with either Dami or Hela NE. A specific band that resulted from the binding of Dami nuclear protein to each oligonucleotide is indicated with an arrowhead.
